Liraglutide May Blunt Impact of Exercise in Dysregulated T2DM

Share this content:
Liraglutide May Blunt Impact of Exercise in Dysregulated T2DM
Liraglutide May Blunt Impact of Exercise in Dysregulated T2DM

THURSDAY, Feb. 16, 2017 (HealthDay News) -- For individuals with dysregulated type 2 diabetes, the addition of the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide may attenuate the impact of exercise, according to a study published online Feb. 11 in Diabetes, Obesity and Metabolism.

Peter G. Jørgensen, from the University of Copenhagen in Denmark, and colleagues examined cardiac function before and after 16 weeks of GLP-1RA liraglutide treatment or placebo combined with supervised exercise among 33 dysregulated patients with type 2 diabetes treated with diet and/or metformin.

The researchers found that early diastolic myocardial tissue velocity improved with exercise in the placebo group (−7.1 ± 1.6 to −7.7 ± 1.8 cm/s; P = 0.01), but no improvement was seen in the liraglutide group (−7.1 ± 1.4 to −7.0 ± 1.4 cm/s; P = 0.60) (between-group difference, P = 0.02). There was improvement in the ratio of early and atrial mitral annular tissue velocities in the placebo group (1.0 ± 0.4 to 1.2 ± 0.4; P = 0.003), but no improvement in the liraglutide group (1.0 ± 0.3 to 1.0 ± 0.3; P = 0.87) (between-group difference, P = 0.03). Heart rate and left ventricular structure or function did not differ significantly within or between the groups.

"Addition of liraglutide to exercise in sedentary patients with dysregulated type 2 diabetes may blunt the suggested beneficial effect of exercise on left ventricular diastolic function," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which funded the study and sponsored the liraglutide and placebo pens.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Plasma Catecholamines Predict Post-Op A-Fib After Cardiac Sx

Plasma Catecholamines Predict Post-Op A-Fib After Cardiac Sx

Composite preoperative catecholamine marker linked to four-fold increased occurrence of POAF

Race, Sex Impact Risk of ESRD for Living Kidney Donors

Race, Sex Impact Risk of ESRD for Living ...

Increased risk of ESRD with black race and male sex; older age tied to increased risk in nonblack donors

Algorithm Integrated Into App Forecasts Glucose Levels

Algorithm Integrated Into App Forecasts Glucose Levels

Method using Gaussian process models produces personalized, nutrition-based forecast

is free, fast, and customized just for you!

Already a member?

Sign In Now »